Stay updated with breaking news from Axion biosystems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NETRI has announced the commercial launch of its NeuroFluidics™ MEA line, developed in collaboration with Axion BioSystems and compatible with the company’s flagship Maestro MultiElectrode Array (MEA) systems. The new product line offers a range of ready-to-use compartmentalized microfluidic devices with an integrated MEA layer, providing high-throughput organs-on-chip platforms for disease research and drug discovery in neurology, dermatology, and other fields. ....
NETRI has announced the commercial launch of its NeuroFluidics™ MEA line, developed in collaboration with Axion BioSystems and compatible with the company’s flagship Maestro MultiElectrode Array (MEA) systems. The new product line offers a range of ready-to-use compartmentalized microfluidic devices with an integrated MEA layer, providing high-throughput organs-on-chip platforms for disease research and drug discovery in neurology, dermatology, and other fields. ....
Deep Learning & AI Igniting Live Cell Imaging Market Expansion the Market to Worth $3.54 Billion by 2028 – Arizton | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
The Omni Pro 12 Live-Cell Imaging Platform from Axion BioSystems Inc. features integrated robotics and a multi-plate design compatible with any standa ....
Axion BioSystems, a leader in live-cell analysis tools, has announced the full integration of imaging innovator CytoSMART Technologies into the Axion BioSystems brand. The news, which follows the company’s 2022 acquisition of CytoSMART Technologies, reflects Axion’s expanding portfolio of live-cell analysis tools for researchers in stem cell biology, immuno-oncology, neurology, virology, toxicology, and other fields. ....